NEW YORK (TheStreet) -- Credit Suisse increased its price target on Wellcare Health Plans (WCG - Get Report) to $85, increased its estimates and set an "outperform" rating. The firm believes the company could boost its guidance.
The stock was down 0.41% to $74.72 just after the market opened on Monday.
Must Read: Warren Buffett's 25 Favorite Stocks
- The revenue growth came in higher than the industry average of 15.7%. Since the same quarter one year prior, revenues rose by 32.3%. Growth in the company's revenue appears to have helped boost the earnings per share.
- The current debt-to-equity ratio, 0.38, is low and is below the industry average, implying that there has been successful management of debt levels. To add to this, WCG has a quick ratio of 1.72, which demonstrates the ability of the company to cover short-term liquidity needs.
- Powered by its strong earnings growth of 104.08% and other important driving factors, this stock has surged by 25.31% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the stock's future course, although almost any stock can fall in a broad market decline, WCG should continue to move higher despite the fact that it has already enjoyed a very nice gain in the past year.
- The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Health Care Providers & Services industry. The net income increased by 104.9% when compared to the same quarter one year prior, rising from $21.52 million to $44.10 million.
- You can view the full analysis from the report here: WCG Ratings Report